Navigation Links
Quintiles Signs Agreement to Acquire Eidetics

Proposed acquisition to augment Quintiles Consulting offerings

RESEARCH TRIANGLE PARK, N.C., May 7 /PRNewswire/ -- Quintiles Transnational Corp. today announced that it has signed an agreement to acquire Eidetics, a privately held decision-analytics and market research consulting firm located in Boston as part of its expanding Quintiles Consulting business.

The acquisition of Eidetics will strengthen Quintiles' core consulting offerings in the areas of product development, commercialization and market access. Quintiles is expanding its consulting practices to help its pharmaceutical, biotech and medical device clients navigate the complex business environment.

"The addition of Eidetics to our Quintiles Consulting business will further strengthen our ability to provide our clients with distinctive, data-driven, strategic solutions to their toughest challenges throughout the product lifecycle," said Jay Norman, President, Quintiles Consulting.

Eidetics has provided research-based market insights and data analytics to support business decision making in drug development and commercialization for the past 20 years and counts among its repeat clients 18 of the top 20 pharmaceutical companies.

"We are looking forward to welcoming the Eidetics team to Quintiles Consulting," Norman said. "They have earned an enviable reputation for strong research and analytics expertise and outstanding client service. Together, we will offer industry-leading strategic consulting, powered by life sciences expertise, operational insights and data analytics."

"We are excited about the opportunity to become part of the Quintiles organization," said Jim Kirk, Partner, Eidetics. "We believe that joining Quintiles Consulting will build upon the past success of Eidetics' business, while providing our clients enhanced clinical, patient and provider data, greater therapeutic depth and access to global resources."

The transaction is contingent upon the completion of certain conditions of the purchase agreement.

About Quintiles Consulting

Quintiles Consulting works with pharmaceutical, biotech and medical device companies to maximize potential and minimize risk from discovery through development and commercialization by providing expert strategic, operational and technical advice. Building on the global reach and expertise of Quintiles Transnational, Quintiles Consulting practice areas include Product Development and Commercialization, Regulatory and Quality, and Market Access. Quintiles Consulting have full-time consultants based across the U.S. and Europe to serve its global clients. For more information, please visit .

About Quintiles

Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, strategic partnering and commercialization for the pharmaceutical, biotechnology and medical device industries. With more than 20,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company's Web site at .

SOURCE Quintiles Transnational Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Quintiles Consulting Business Expands
2. Quintiles Completes Previously Announced New Investor Partnership, Co-Led by Founder, Chairman and CEO Dennis Gillings, Bain Capital, TPG and 3i
3. Quintiles to Open Clinical Research Office in Wilmington, NC
4. Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility
5. Quintiles Names Kelly McKee Executive Director of Operations for Public Health and Government Services Unit
6. Expert Cardiologist Joins Quintiles Medical Group
7. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
8. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
9. Assay Designs(TM) Announces Collaboration with Medical University of South Carolina (MUSC)
10. Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation
11. DelSite Signs Technology Evaluation Agreement With Global Pharmaceutical Company for GelSite(R) Polymer
Post Your Comments:
(Date:11/24/2015)... 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or "the ... results for the quarter ended September 30, 2015. ... dollars and presented under International Financial Reporting Standards ... ," said Andrew Rae , President & ... are not only value enriching for this clinical ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
(Date:11/24/2015)... November 24, 2015 SHPG ) announced today ... the Piper Jaffray 27 th Annual Healthcare Conference in ... 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ... Officer, will participate in the Piper Jaffray 27 th Annual ... on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. ...
(Date:11/24/2015)... SAN FRANCISCO , Nov. 24, 2015 /PRNewswire/ ... today announced that Emily Leproust, Ph.D., Twist Bioscience ... Piper Jaffray Healthcare Conference on December 1, 2015 ... Palace Hotel in New York City. ... . Twist Bioscience is on ...
Breaking Biology Technology:
(Date:10/27/2015)... , Oct. 27, 2015 In the present ... of concern for various industry verticals such as banking, ... to the growing demand for secure & simplified access ... ,sectors, such as hacking of bank accounts, misuse of ... equipment such as PC,s, laptops, and smartphones are expected ...
(Date:10/26/2015)... LAS VEGAS , Oct. 26, 2015 ... an innovator in modern authentication and a founding member ... launch of its latest version of the Nok Nok™ ... to use standards-based authentication that supports existing and emerging ... Suite is ideal for organizations deploying customer-facing applications that ...
(Date:10/22/2015)... 2015  Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... third quarter ended September 30, 2015.  --> ... was $4.0 million, a decrease of 33% compared to $6.0 million ... quarter of 2015 was $2.2 million, or $0.10 per diluted share, ... the same period a year ago.  --> ...
Breaking Biology News(10 mins):